Campbell & Co Investment Adviser’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,085
| Closed | -$8.15M | – | 1105 |
|
|
2024
Q4 | $8.15M | Buy |
22,085
+11,806
| +115% | +$4.36M | 0.63% | 7 |
|
|
2024
Q3 | $5.35M | Buy |
+10,279
| New | +$5.35M | 0.4% | 31 |
|
|
2024
Q2 | – | Sell |
-1,778
| Closed | -$922K | – | 1120 |
|
|
2024
Q1 | $922K | Buy |
+1,778
| New | +$922K | 0.08% | 434 |
|
|
2023
Q4 | – | Sell |
-5,755
| Closed | -$2.51M | – | 1159 |
|
|
2023
Q3 | $2.51M | Buy |
5,755
+4,280
| +290% | +$1.86M | 0.3% | 56 |
|
|
2023
Q2 | $655K | Buy |
1,475
+777
| +111% | +$345K | 0.12% | 303 |
|
|
2023
Q1 | $321K | Buy |
+698
| New | +$321K | 0.06% | 582 |
|
|
2022
Q4 | – | Sell |
-1,527
| Closed | -$694K | – | 821 |
|
|
2022
Q3 | $694K | Buy |
+1,527
| New | +$694K | 0.16% | 213 |
|
|
2022
Q2 | – | Sell |
-1,392
| Closed | -$684K | – | 736 |
|
|
2022
Q1 | $684K | Buy |
+1,392
| New | +$684K | 0.18% | 171 |
|
|
2020
Q3 | – | Sell |
-1,189
| Closed | -$313K | – | 405 |
|
|
2020
Q2 | $313K | Buy |
+1,189
| New | +$313K | 0.4% | 96 |
|
|
2020
Q1 | – | Sell |
-4,924
| Closed | -$1.49M | – | 173 |
|
|
2019
Q4 | $1.49M | Buy |
4,924
+3,023
| +159% | +$913K | 0.46% | 22 |
|
|
2019
Q3 | $456K | Buy |
+1,901
| New | +$456K | 0.17% | 212 |
|
|
2018
Q3 | – | Sell |
-1,548
| Closed | -$368K | – | 431 |
|
|
2018
Q2 | $368K | Buy |
1,548
+300
| +24% | +$71.3K | 0.28% | 128 |
|
|
2018
Q1 | $274K | Buy |
+1,248
| New | +$274K | 0.23% | 198 |
|
|
2017
Q4 | – | Sell |
-1,382
| Closed | -$262K | – | 427 |
|
|
2017
Q3 | $262K | Sell |
1,382
-537
| -28% | -$102K | 0.21% | 194 |
|
|
2017
Q2 | $361K | Buy |
+1,919
| New | +$361K | 0.34% | 96 |
|
|
2015
Q3 | – | Sell |
-2,794
| Closed | -$459K | – | 342 |
|
|
2015
Q2 | $459K | Buy |
+2,794
| New | +$459K | 0.39% | 86 |
|